The National Practice Patterns of Venous Thromboembolism Prophylaxis Post-Cardiothoracic Surgery

Abstract

Background:

The rates of venous thromboembolism (VTE) post-cardiothoracic surgery are not well understood. The american college of chest physicians (CHEST) guidelines report weak recommendations for starting VTE prophylaxis post-cardiothoracic surgery. It is suspected that due to the increase in bleed risk, postsurgery initiation of pharmacologic VTE prophylaxis is limited.

Objective:

The study sought to investigate the use of VTE prevention in US hospitals performing cardiac surgery and the use of mechanical/chemical prophylaxis postoperatively.

Methods:

This is a multicenter survey distributed to cardiac hospitals in the United States. The survey was distributed through 3 separate listservs. Data were analyzed utilizing descriptive statistics.

Results:

The majority of the hospitals were academic and/or community and completed coronary artery bypass graft (CABG), valve replacement (mitral/aortic/tricuspid), and aortic repair. It was common for hospitals to start mechanical and pharmacologic prophylaxis post-cardiothoracic surgery on postoperative day (POD) 1 to 2. The anticoagulation most commonly used consisted of unfractionated heparin.

Conclusions:

The majority of the institutions are initiating therapy POD 1 to 2 with both mechanical and chemical prophylaxis. The full impact of early initiation of VTE prophylaxis is unknown, and more studies are needed to assess the true risks/benefits of these practices.

Keywords

venous thromboembolism prophylaxis post-cardiac surgery survey mechanical prophylaxis chemical prophylaxis

Get full access to this article

View all access options for this article.

References

Hannan

Racz

Walfod

. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA. 2003;290(6):773–780.

White

Zhou

Romano

. Incidence on symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446–455.

Goldhaber

Schoepf

. Pulmonary embolism after coronary artery bypass grafting. Circulation. 2004;109(22):2712–2715.

Gould

Garcia

Wren

. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e227S–e277S.

VTE 2-Core Measure: intensive care unit venous thromboembolism prophylaxis. Web site. http://www.jointcommission.org/specifications_manual_for_national_hospital_inpatient_quality_measures.aspx.2008. Published May 1, 2008. Accessed March 10, 2015.

Aziz

Patel

Ortenzi

. Incidence of postoperative deep venous thrombosis is higher among cardiac and vascular surgery patients as compared with general surgery patients. Ann Vasc Surg. 2015;29(4):661–669.

Mirhosseini

Forouzannia

Manshadi

. Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial. Cardiol J. 2013;20(2):139–143.

Di Nisio

Peinemann

Porreca

. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. Cochrane Database Syst Rev. 2015;6:CD009658.

Kolluri

. A study of the efficacy of preventative dosing of fondaparinux sodium versus placebo for the prevention of venous thromboembolism (VTE) in patients undergoing coronary artery bypass graft surgery receiving routine mechanical prophylaxis. Web site. https://clinicaltrials.gov/ct2/show/NCT00789399?term=00789399&rank=1. Accessed June 21, 2015.